NCT06718777

Brief Summary

Pressure injuries are a condition that reduces patients' quality of life, increases hospitalization time and healthcare costs. When accompanied by infection and complications, mortality increases. The primary goal in pressure injuries is to prevent their occurrence, but once the injury has occurred, it is to provide effective and appropriate care. It is known that 0.9% sodium chloride (NaCl) is used routinely in pressure ulcer care. In addition, if the effectiveness of 0.1% polyhexanide in pressure ulcer care is demonstrated, it may provide data for its use in wound care. For this purpose, the study was completed as a randomized controlled trial with 32 individuals in the 0.1% polyhexanide group and 31 individuals in the 0.9% NaCl group, totaling 63 individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 5, 2024

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

November 4, 2024

Last Update Submit

December 4, 2024

Conditions

Keywords

pressure injury%0.1 poliheksanit solution%0.9 sodium chloride

Outcome Measures

Primary Outcomes (1)

  • PUSH score

    This scale, developed by NPUAP to evaluate the healing process of pressure injuries, was used in the study to evaluate the healing status of pressure injuries in patients receiving pressure injury care. The pressure injury healing status was monitored with the evaluation criteria in the scale. The lowest score to be received from PUSH is 0, and the highest score is 17. A decrease in the score indicates that the pressure injury has healed.

    From 0th hour to 144th hour

Secondary Outcomes (1)

  • NPUAP Pressure Sore Classification System

    0th hour

Study Arms (2)

0.1% polyhexanide

EXPERIMENTAL

0.1% polyhexanide solution was applied 3 times at 48-hour intervals for pressure ulcer care.

Other: 0.1% polyhexanide Care

0.9% NaCl

EXPERIMENTAL

0.9% sodium chloride solution was applied three times at 48-hour intervals for pressure ulcer care.

Other: 0.9 % NaCl Care

Interventions

After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.1% polyhexanide solution. Then, 2 treatments were performed at 48-hour intervals and PUSH scores were recorded before each care. A total of three pressure ulcer care and four follow-ups were performed.

0.1% polyhexanide

After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.9% sodium chloride. Then, 2 care sessions were performed at 48-hour intervals and PUSH scores were recorded before each care. A total of three pressure ulcer care sessions and four follow-ups were performed.

0.9% NaCl

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over the age of 18 who have developed pressure injuries
  • Patients who have received informed consent from themselves or their guardians

You may not qualify if:

  • Patients with clotting problems
  • Patients using corticosteroids
  • Patients receiving additional medical treatment for wound care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gazi Yaşargil Training and Research Hospital

Diyarbakır, 21000, Turkey (Türkiye)

Location

Gazi Yaşargil Training and Research Hospital

Diyarbakır, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Mensure Turan, PhD

    Şırnak Üniversitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Asistant Professor

Study Record Dates

First Submitted

November 4, 2024

First Posted

December 5, 2024

Study Start

August 1, 2023

Primary Completion

January 1, 2024

Study Completion

August 1, 2024

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations